Publications

6444 items matching your search terms.

Paradoxically low levels of total and HMW adiponectin in relation to metabolic parameters in a Tongan population

Peake, P.; Colagiuri, S.; Campbell, L. V. ; Shen, Y.;

ISRN Endocrinol 2013 :873507, 2013

TGF-beta modulates ovarian cancer invasion by upregulating CAF-derived versican in the tumor microenvironment

Yeung, T. L.; Leung, C. S.; Wong, K. K.; Samimi, G.; Thompson, M. S.; Liu, J.; Zaid, T. M.; Ghosh, S.; Birrer, M. J.; Mok, S. C.;

CANCER RESEARCH 73 (16) :5016-28, 2013

Fibroblast growth factor receptor 1 (FGFR1) copy number is an independent prognostic factor in non-small cell lung cancer

Tran, T. N.; Selinger, C. I.; Kohonen-Corish, M. R.; McCaughan, B. C.; Kennedy, C. W.; O'Toole, S. A.; Cooper, W. A.;

LUNG CANCER 81 (3) :462-7, 2013

Effects of low-dose prednisolone on hepatic and peripheral insulin sensitivity, insulin secretion, and abdominal adiposity in patients with inflammatory rheumatologic disease

Petersons, C. J. Mangelsdorf, B. L. Jenkins, A. B. Poljak, A. Smith, M. D. Greenfield, J. R. Thompson, C. H. Burt, M. G.;

DIABETES CARE 36 (9) :2822-9, 2013

L-arginine and Vitamin D adjunctive therapies in pulmonary tuberculosis: A randomised, double-blind, placebo-controlled trial

Ralph, A.P.; Waramori, G.; Pontoring, G.J.; Kenangalem, E.; Wiguna, A.; Tjitra, E.; Sandjaja, Lolong, D.B.; Yeo, T.W.; Chatfield, M.D.; Soemanto, R.K.; Bastian, I.; Lumb, R.; Maguire, G.P.; Eisman, J.; Price, R.N.; Morris, P.S.; Kelly, P.M.; Anstey, N.M.

PLoS One 8 (8) :e70032, 2013 10.1371/journal.pone.0070032

Metabolomics: an important tool for assessing state of health and risk of disease in nutrigenomics research

Lin, H.; Rowan, D.D.

Nutrigenomics and Nutrigenetics in Functional Foods and Personalized Nutrition chapter 11 :229-242, 2013

Neuropilin-2 promotes extravasation and metastasis by interacting with endothelial alpha5 integrin

Cao, Y. ; Hoeppner, L. H. ; Bach, S. ; E, G. ; Guo, Y.; Wang, E. ; Wu, J. ; Cowley, M. J. ; Chang, D. K. ; Waddell, N. ; Grimmond, S. M. ; Biankin, A. V. ; Daly, R. J. ; Zhang, X. ; Mukhopadhyay, D.;

CANCER RESEARCH 73 (14) :4579-90, 2013

Could the properties of IL-27 make it an ideal adjuvant for anticancer immunotherapy?

Swarbrick, A.; Junankar, S. R.; Batten, M.;

Oncoimmunology 2 (8) :e25409, 2013

Adiposity and insulin resistance in humans: the role of the different tissue and cellular lipid depots

Hocking, S.; Samocha-Bonet, D.; Milner, K. L.; Greenfield, J. R.; Chisholm, D. J.

ENDOCRINE REVIEWS 34 :463-500, 2013 10.1210/er.2012-1041

Signal transducer and activator of transcription 3 (STAT3) mutations underlying autosomal dominant hyper-IgE syndrome impair human CD8(+) T-cell memory formation and function

Ives, M. L.; Ma, C. S.; Palendira, U.; Chan, A.; Bustamante, J.; Boisson-Dupuis, S.; Arkwright, P. D.; Engelhard, D.; Averbuch, D.; Magdorf, K.; Roesler, J.; Peake, J.; Wong, M.; Adelstein, S.; Choo, S.; Smart, J. M.; French, M. A.; Fulcher, D. A.; Cook, M. C.; Picard, C.; Durandy, A.; Tsumura, M.; Kobayashi, M.; Uzel, G.; Casanova, J. L.; Tangye, S. G.; Deenick, E. K.;

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY 132 (2) :400-411 e9, 2013 10.1016/j.jaci.2013.05.029

Molecular engineering of therapeutic cytokines

Vazquez-Lombardi, R.; Roome, B.; Christ, D.

Antibodies 2 :426-451, 2013 10.3390/antib2030426

beta-Catenin signaling is a critical event in ErbB2-mediated mammary tumor progression

Schade, B. Lesurf, R. Sanguin-Gendreau, V. Bui, T. Deblois, G. O'Toole, S. A. Millar, E. K. Zardawi, S. J. Lopez-Knowles, E. Sutherland, R. L. Giguere, V. Kahn, M. Hallett, M. Muller, W. J.;

CANCER RESEARCH 73 (14) :4474-87, 2013

Inherited human OX40 deficiency underlying classic Kaposi sarcoma of childhood

Byun, M.; Ma, C. S.; Akcay, A.; Pedergnana, V.; Palendira, U.; Myoung, J.; Avery, D. T.; Liu, Y.; Abhyankar, A.; Lorenzo, L.; Schmidt, M.; Lim, H. K.; Cassar, O.; Migaud, M.; Rozenberg, F.; Canpolat, N.; Aydogan, G.; Fleckenstein, B.; Bustamante, J.; Picard, C.; Gessain, A.; Jouanguy, E.; Cesarman, E.; Olivier, M.; Gros, P.; Abel, L.; Croft, M.; Tangye, S. G.; Casanova, J. L.

JOURNAL OF EXPERIMENTAL MEDICINE 210 (9) :1743-59, 2013 10.1084/jem.20130592

BCL-2 hypermethylation is a potential biomarker of sensitivity to anti-mitotic chemotherapy in endocrine-resistant breast cancer.

Stone, A.; Cowley, M.J.; Valdes-Mora, F.; McCloy, R.; Sergio, C.M.; Gallego-Ortega, D.; Caldon, C. E.; Ormandy, C.J.; Biankin, A.V.; Gee, J. M.; Nicholson, R. I.; Print, C.G.; Clark, S.J.; and Musgrove, E.A.;

MOLECULAR CANCER THERAPEUTICS :Submitted, 2013

B-lymphocyte therapy for Type 2 diabetes: the ?B? side of diabetic medication?

Grey, S. T.

Immunotherapy 5 (7) :669-72, 2013 10.2217/imt.13.52

An algorithm for generating small RNAs capable of epigenetically modulating transcriptional gene silencing and activation in human cells

Ackley, A.; Lenox, A.; Stapleton, K.; Knowling, S.; Lu, T.; Sabir, K. S.; Vogt P. K. ; Morris, K. V.

MOLECULAR THERAPY 2 :e104, 2013 10.1038/mtna.2013.33